Tumor-induced perturbations of cytokines and immune cell networks
about
Producer T cells: Using genetically engineered T cells as vehicles to generate and deliver therapeutics to tumorsThe application of the fibroblast activation protein α-targeted immunotherapy strategyThe Roles of Mesenchymal Stromal/Stem Cells in Tumor Microenvironment Associated with InflammationAn Autocrine Cytokine/JAK/STAT-Signaling Induces Kynurenine Synthesis in Multidrug Resistant Human Cancer CellsFighting the force: Potential of homeobox genes for tumor microenvironment regulationCXCR2 signaling regulates KRAS(G¹²D)-induced autocrine growth of pancreatic cancer.Reversing EGFR Mediated Immunoescape by Targeted Monoclonal Antibody TherapyReducing liver metastases of colon cancer in the context of extensive and minor surgeries through β-adrenoceptors blockade and COX2 inhibitionNiche inheritance: a cooperative pathway to enhance cancer cell fitness through ecosystem engineering.The quantum of initial transformed cells potentially modulates the type of local inflammation mechanism elicited by surrounding normal epithelial tissues and systemic immune pattern for tumor arrest or progression.Favorable alteration of tumor microenvironment by immunomodulatory cytokines for efficient T-cell therapy in solid tumorsCervical (pre)neoplastic microenvironment promotes the emergence of tolerogenic dendritic cells via RANKL secretion.Leptin produced by obese adipose stromal/stem cells enhances proliferation and metastasis of estrogen receptor positive breast cancers.In vivo screening and discovery of novel candidate thalidomide analogs in the zebrafish embryo and chicken embryo model systems.Improved Chemotherapeutic Activity by Morus alba Fruits through Immune Response of Toll-Like Receptor 4.Nanoparticle-Based Manipulation of Antigen-Presenting Cells for Cancer Immunotherapy.Tumor Presence Induces Global Immune Changes and Enhances Nanoparticle ClearanceInvestigating the Radioresistant Properties of Lung Cancer Stem Cells in the Context of the Tumor MicroenvironmentCurcumin Micelles Remodel Tumor Microenvironment and Enhance Vaccine Activity in an Advanced Melanoma Model.Progress in Adaptive Immunotherapy for Cancer in Companion Animals: Success on the Path to a Cure.Evaluation of 29 indicators for the prognosis of advanced non-small cell lung cancer with cytokine-induced killer cell therapy combined with chemotherapyTH9 cells in anti-tumor immunity.Polymorphism of the IL13 gene may be associated with Uterine leiomyomas in Slovenian womenPreoperative neutrophil-lymphocyte ratio can significantly predict mortality outcomes in patients with non-muscle invasive bladder cancer undergoing transurethral resection of bladder tumor.Intracellular STING inactivation sensitizes breast cancer cells to genotoxic agents.Insights into Local Tumor Microenvironment Immune Factors Associated with Regression of Cutaneous Melanoma Metastases by Mycobacterium bovis Bacille Calmette-Guérin.Cysteine-linked dimerization of BST-2 confers anoikis resistance to breast cancer cells by negating proapoptotic activities to promote tumor cell survival and growth.Stroma as an Active Player in the Development of the Tumor Microenvironment.Chemokines in the melanoma metastasis biomarkers portrait.Ecology meets cancer biology: the cancer swamp promotes the lethal cancer phenotype.Serum biomarker analysis in patients with recurrent spontaneous abortion.Tumor immunotherapy: drug-induced neoantigens (xenogenization) and immune checkpoint inhibitors.Rationale for immune-based therapies in Merkel polyomavirus-positive and -negative Merkel cell carcinomas.Oncogenic growth factor signaling mediating tumor escape from cellular immunity.Dual role of inflammatory mediators in cancer.Expanding Diversity and Common Goal of Regulatory T and B Cells. II: In Allergy, Malignancy, and Transplantation.Metabolic reprogramming in the tumour microenvironment: a hallmark shared by cancer cells and T lymphocytes.Regular Aspirin Use Associates With Lower Risk of Colorectal Cancers With Low Numbers of Tumor-Infiltrating Lymphocytes.Smac mimetics and oncolytic viruses synergize in driving anticancer T-cell responses through complementary mechanisms.Cytokine response to the RSV antigen delivered by dendritic cell-directed vaccination in congenic chicken lines.
P2860
Q26741260-8D6A504C-E156-4782-80CF-61B240089CF5Q28073437-D3BAC7AA-D3E0-4138-878D-DBF158E8B15CQ28073691-FC3C44A3-0E38-4A5B-9CDF-CF73D30BB9B1Q28547142-62C0FC0C-C000-496F-AFE7-547228065F8DQ28547302-533162C4-03FD-4571-B26F-BC110F758616Q30358993-E3030961-BB8F-424F-994D-2DD22C89D69BQ33736664-359C0C91-9F46-46C0-A73F-DB19F62AC050Q33871656-688FC41C-7C42-463C-8356-E309F8C35BC5Q34086276-FDE5F6C3-F362-49C2-AF9F-EA901F2C14BDQ34791671-8A74F155-476A-40B1-B830-343034977AFDQ35673240-8B3470E8-CA5F-4621-8BB9-241B88A0AA74Q35798899-AACCB37B-B0DA-456A-8373-8F40ECC8B541Q35971435-208B6CDC-D050-4037-AD63-6C2E84DCE3BAQ36001001-1AF061DC-9694-4AFB-A1DE-613BABDF87E4Q36247376-80D23A3A-E7A9-4DF2-9B44-BAC66FF8DCC4Q36269694-98015AFD-51D5-465E-B780-3D3B51EDBA96Q36600153-4F391DBA-637B-4351-847A-9C488F240986Q36603426-E66F1AB6-6A5C-403F-9356-4B8FCE9EB81DQ36756833-365B7FC4-495C-4CAF-AB99-29A4C554B030Q36781992-271E598D-3687-439F-B6C0-D7CE9DCD8A6DQ36824656-432D4603-676B-462F-AF06-43C707C1C824Q37575177-0E154A2F-2850-47DD-8F8E-D5A1E58D621AQ37689995-4EA90FE4-FA39-4841-AAEE-FC27FE676FA0Q37706516-9BFABC49-7881-46D0-A5EF-80FF65D38466Q37718357-A8E35323-8F7F-4632-9DA5-EF33020DAA4DQ37737540-F1F81964-A048-4845-81C7-D3C9C6963EB2Q37745522-DC081A96-DBF8-486F-998A-A0E74807515AQ38238231-D33DB5CB-A449-4B41-8E74-6A477209EE44Q38403945-04003887-4440-4193-BE01-4A445D12D6F5Q38430999-9823CD7D-CC10-4B9A-A638-3DBA276B8DECQ38693339-7D37CCB7-629F-4101-8A26-CDDA5C8A62E1Q38730989-20866B14-6771-427E-A5FC-F9E487442E91Q38887303-4C03241B-C5D9-4DEF-94D3-2FDF6A46AB07Q39139069-D2BC3EBC-7FF4-40BF-8299-25D55CFE5713Q39169516-80B57AEE-4BDC-477B-8B20-5948291BEBC1Q39282520-F4992A63-F365-45BE-99FE-099F94F32E9CQ39378337-E2E9526D-30DA-4BA3-A88B-8B9725C98465Q39542382-5C0322F7-FCF3-43CC-8D58-11C2DC8E46BFQ40071126-73A73942-1E7E-4E2E-ABF1-C5C6ABDFAF65Q40256165-1A0D4AE8-210E-4320-8176-8DA0AB580531
P2860
Tumor-induced perturbations of cytokines and immune cell networks
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Tumor-induced perturbations of cytokines and immune cell networks
@ast
Tumor-induced perturbations of cytokines and immune cell networks
@en
Tumor-induced perturbations of cytokines and immune cell networks
@nl
type
label
Tumor-induced perturbations of cytokines and immune cell networks
@ast
Tumor-induced perturbations of cytokines and immune cell networks
@en
Tumor-induced perturbations of cytokines and immune cell networks
@nl
prefLabel
Tumor-induced perturbations of cytokines and immune cell networks
@ast
Tumor-induced perturbations of cytokines and immune cell networks
@en
Tumor-induced perturbations of cytokines and immune cell networks
@nl
P2093
P3181
P1476
Tumor-induced perturbations of cytokines and immune cell networks
@en
P2093
Bao-Ling Wang
Brett Burkholder
Chang-Yu Gao
Ren-Yu Huang
Rob Burgess
Ruo-Pan Huang
Shuhong Luo
Valerie Sloane Jones
Wenji Zhang
Yu-Ming Zhang
P304
P3181
P356
10.1016/J.BBCAN.2014.01.004
P407
P577
2014-04-01T00:00:00Z